Make Your First AppointmentGet a Second Opinion
Call us: 877-442-3324
The Susan F. Smith Center for Women's Cancers at Dana-Farber unites many of the world's leading experts in breast and gynecologic cancers with one common goal: to give all women the latest, most advanced care, including innovative therapies that are often available only through clinical trials.
A place of hope and action, the Susan F. Smith Center for Women's Cancers offers multi-dimensional services to strengthen mind, body, and soul and to help alleviate mental and emotional burdens. Ending women's cancers are the reason we exist. Everything we do – from the moment a patient pulls into the parking lot until the moment they leave the building after their last treatment – is tailored to the unique needs of women.
Donna GregoryCancer patient
Researchers in the Susan F. Smith Center for Women's Cancers are conducting approximately 90 clinical trials exploring new and better tools and treatments. Our work in laboratory discoveries, drug development, and clinical applications has led to the advent of many targeted therapies. And, as a biotech engine within a care setting, we have the unique ability to bring treatment innovations to patients as quickly as possible.
At the Susan Smith Center for Women's Cancers, the patient is at the center of everything we do including our clinical trials that focus on the types and phases of your disease so therapy can be targeted to your type of women's cancer.
Our current clinical trials underway in breast cancer include:
In gynecologic cancer, our current clinical trial work focuses on patients with:
Learn more about current cancer genetic studies.
Support Research and Treatment at the Susan F. Smith Center
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: